Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes

OBJECTIVE: Iguratimod, a novel disease-modifying anti-rheumatic drug for the treatment of rheumatoid arthritis, has been approved in China and Japan. Here, we aimed to find whether iguratimod can inhibit the aggressive behavior and promote apoptosis of rheumatoid fibroblast-like synoviocytes (RA-FLS...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Immunol Res
Auteurs principaux: Lin, Jin, Yu, Ye, Wang, Xuanwei, Ke, Yini, Sun, Chuanyin, Yue, Lihuan, Xu, Guanhua, Xu, Bei, Xu, Liqin, Cao, Heng, Xu, Danyi, Olsen, Nancy, Chen, Weiqian
Format: Artigo
Langue:Inglês
Publié: Hindawi 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885276/
https://ncbi.nlm.nih.gov/pubmed/31828173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6929286
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires